KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 99 filers reported holding KYMERA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,086,376 | -57.7% | 150,099 | -30.0% | 0.01% | -57.1% |
| Q2 2023 | $4,931,125 | -20.4% | 214,490 | +2.6% | 0.03% | -33.3% |
| Q1 2023 | $6,195,307 | +15.1% | 209,089 | -3.0% | 0.04% | -6.7% |
| Q4 2022 | $5,380,752 | +37.6% | 215,575 | +20.0% | 0.04% | +7.1% |
| Q3 2022 | $3,911,000 | +32.1% | 179,642 | +19.5% | 0.04% | +55.6% |
| Q2 2022 | $2,960,000 | -43.7% | 150,339 | +21.1% | 0.03% | -12.9% |
| Q1 2022 | $5,253,000 | -13.6% | 124,128 | +29.6% | 0.03% | -3.1% |
| Q4 2021 | $6,081,000 | +121.4% | 95,776 | +104.9% | 0.03% | +68.4% |
| Q3 2021 | $2,746,000 | +9.7% | 46,749 | -9.4% | 0.02% | +18.8% |
| Q2 2021 | $2,503,000 | +24.3% | 51,601 | -0.4% | 0.02% | +14.3% |
| Q1 2021 | $2,013,000 | – | 51,810 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81,429,842 | 12.61% |
| Aquilo Capital Management, LLC | 782,219 | $10,872,844 | 9.85% |
| BVF INC/IL | 4,739,004 | $65,872,156 | 1.78% |
| Redmile Group, LLC | 1,868,507 | $25,972,247 | 1.24% |
| Artal Group S.A. | 1,805,346 | $25,094 | 1.08% |
| Deer Management Co. LLC | 615,895 | $8,560,941 | 1.04% |
| Avoro Capital Advisors LLC | 3,855,000 | $53,584,500 | 0.84% |
| Rock Springs Capital Management LP | 1,504,351 | $20,910,479 | 0.56% |
| AtonRa Partners | 19,172 | $266,491 | 0.56% |
| Baker Brothers Advisors | 4,750,400 | $66,030,560 | 0.38% |